Vincentage Pharma Co., Ltd

This study looked at how two common drugs, rifampin and itraconazole, change the way the body processes a new experimental medicine called VCT220, which is being developed for obesity. Thirty-two healthy adults took part, with each person receiving either rifampin or itraconazole…

This study looked at how a new medicine called VCT220 interacts with three common drugs (repaglinide, rosuvastatin, and digoxin) in 24 healthy overweight adults. Participants took the drugs alone and then with VCT220 to measure changes in drug levels and safety. The goal was to g…

This study looked at how a single dose of the experimental drug VCT220 behaves in 16 people with moderate kidney problems compared to 16 people with normal kidneys. The goal was to see if kidney function changes drug levels and safety. Results will help doctors decide the right d…